COPD Management Guidelines

Introduction to COPD Management

The American Thoracic Society recommends that smoking cessation is the single most important intervention for all COPD patients, as it is the only intervention besides long-term oxygen therapy proven to modify disease progression and survival 1, 2

Nicotine replacement therapy combined with behavioral interventions achieves higher sustained quit rates than simple advice alone, with success rates up to 30% 3, 1
Patients typically require multiple attempts through cycles of contemplation, action, and relapse before achieving sustained cessation 3
Abrupt cessation is more successful than gradual withdrawal, though relapse rates remain high 3

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends that symptomatic patients with mild COPD should receive short-acting bronchodilators as needed via appropriate inhaler device 1, 2
For moderate COPD, the American College of Chest Physicians recommends initiating long-acting bronchodilator monotherapy as first-line treatment 5, 1, 2
For severe COPD, the European Respiratory Society recommends initiating LABA/LAMA combination therapy as first-line treatment, as it provides superior bronchodilation and exacerbation prevention compared to monotherapy or LABA/ICS combinations 5, 1, 2

The American Thoracic Society recommends that short-acting inhaled β2-agonists, with or without short-acting anticholinergics, are the initial bronchodilators for acute exacerbations 6, 2
Systemic corticosteroids, such as 40 mg prednisone daily for 5 days, improve FEV1, oxygenation, shorten recovery time, and reduce hospitalization duration 6, 1, 2
Antibiotics should be prescribed when ≥2 of the following are present: increased breathlessness, increased sputum volume, purulent sputum 1, 2

The American Thoracic Society recommends that patients with high symptom burden should participate in comprehensive pulmonary rehabilitation programs including physiotherapy, muscle training, nutritional support, and education 5, 1, 2
Long-term oxygen therapy should be prescribed for patients with PaO2 ≤55 mmHg, with goal of maintaining SpO2 ≥90% during rest, sleep, and exertion 1, 2
Annual influenza vaccination is recommended for all COPD patients, as it reduces mortality by 70% in elderly patients with COPD 4, 1, 2

Beta-blocking agents must be avoided in COPD patients 1, 2
Prophylactic antibiotics have no evidence of benefit and should not be used except in rare cases of frequently recurring infections 4, 3, 2
Theophyllines have limited value in routine COPD management due to side effects and should only be tried in severe disease with monitoring 4, 1, 2